Dr Mollie V. Willliams joins Ethics Talk to discuss her article, coauthored with Dr Olaitan Ajisafe: “How Should Exposure Risk to Tactical Personnel Be Balanced Against Clinical and Ethical Rescue Demand?”
Dr Natalie Bonfine joins Ethics Talk to discuss her article, coauthored with Dr Mark R. Munetz: “Crisis Intervention Team Program Leadership Must Include Psychiatrists.”
Dr Amy Watson joins Ethics Talk to discuss how crisis intervention teams can motivate efficiency and equity in tactical responses to 911 calls and what community mental health intervention might look like when we think beyond the limits of law enforcement response.
This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing.
AMA J Ethics. 2021; 23(6):E471-479. doi:
10.1001/amajethics.2021.471.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021; 23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Kim Christiansen discusses her experiences managing limited mobility and chronic pain from a partial spinal cord injury and Dr Natalie Hoff describes good physical therapy care for patients with chronic migraine headaches.